Global Retirement Partners’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
ISL
PA
Global Retirement Partners's CORT Position: Q2 2026 in Review
Global Retirement Partners opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 226 shares worth $19.7K. The stake represents ﹤0.01% of the portfolio and ranks #3071 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in CORT as recently as Q4 2025.
Global Retirement Partners first reported a position in CORT in Q2 2018 and has held it in 20 quarters since. The position peaked at $120K in Q2 2024. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- Global Retirement Partners held 226 shares of Corcept Therapeutics worth $19.7K as of Q2 2026.
- Corcept Therapeutics was a new Global Retirement Partners position in Q2 2026.
- Corcept Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3071 holding.
- Global Retirement Partners first reported a position in Corcept Therapeutics in Q2 2018 and has held it in 20 quarters since.
- Global Retirement Partners's Corcept Therapeutics position peaked at $120K in Q2 2024.
- 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.